Master, Integrated Masters in Natural or Agricultural or Pharmaceutical Sciences, Animal Sciences OR Bachelors degree in Engineering or Technology or Medicine from a recognized University
The posts in the advertisement are not regular posts of the State Government but purely contractual posts. There will be no right of permanence on the said posts and the Government service rules are not applicable for these posts, nor will the applicant be entitled to inclusion in the Government regular service or service protection through the Government or to claim in this regard.
D.Pharma in aggregate and registered with State Pharmacy Council or Pharmacy Council of India. Individuals qualified in B.Pharma. Applications invited from Domiciles of Districts Of Tamil Nadu, Andhra Pradesh, Telangana, Union Territory Puducherry (Karaikal, Yanam & Puducherry) And Andaman & Nicobar Island (Nicobar, North & Middle Andaman And South Andaman)
Junior Research Fellow to work under the research project entitled Wastewater to biofuel and bio products : Cyanobacterial bio refinery through a green circular bio-economy.
D.Pharma with minimum 55% in aggregate and registered with State Pharmacy Council, Pharmacy Council of India. Individuals qualified in B.Pharma with minimum 50% marks and registered with State Pharmacy Council, Pharmacy Council of India will also be eligible.
Synthesis of polymer conjugates via different chemistry, preparation of microbeads with X-ray imaging moieties, physicochemical characterization, study the drug loading and release kinetics, biocompatibility evaluation, data collection and interpretation, preparation of reports.
AstraZeneca and Alteogen Inc. have entered into an exclusive license agreement for ALT-B4, a novel hyaluronidase utilising Hybrozyme platform technology. Under the terms of the agreement, AstraZeneca will acquire worldwide rights to use ALT-B4 to develop and commercialise subcutaneous formulations of several oncology assets. Alteogen will be responsible for clinical and commercial supply of ALT-B4 to AstraZeneca.
Zydus Life sciences Limited has received final approval from the United States Food and Drug Administration USFDA to manufacture Apalutamide Tablets, 60 mg.
A previously unknown protein in a family of bacteria found in soil and the human gut microbiome has been discovered – which could help drug delivery in cancer treatment. In a paper published in PNAS, researchers at King’s College London and the University of Washington describe the unique 3D structure of this protein, which is now being used to develop cancer drug delivery systems that can target drugs to tumour sites.
TARO Pharmaceuticals Inc., a subsidiary of Sun Pharma, has completed 100 percent acquisition of Antibe Therapeutics Inc., Canada for a total consideration of CAD 4.5 million.
Antibe Therapeutics is an Ontario, Canada incorporated corporation based in Ontario, Canada. It is a clinical-stage biotechnological company developing novel drugs primarily focusing on reducing pain and inflammation.
Janus kinase inhibitors are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohns disease or ulcerative colitis. Since their approval, the indications for these medical drugs have steadily increased, but recently safety concerns have also been raised.
Master Degree in Chemistry, Chemical Sciences, Pharmaceutical Sciences, Pharmaceutical Chemistry with two years of research experience. Master Degree in Botany, Biotechnology, Plant Sciences, Life Sciences with two-year experience & NET-LS, GATE, NET-JRF qualified 02 Year experience in Plant Molecular biology, Biotechnology, Botany, Plant Tissue Culture, cloning and protein expression.
Rational design, synthesis and evaluation of novel nitrogen-bearing heterocyclic hybrids as allosteric SH-2 domain- containing protein tyrosine phosphatase-2 inhibitors for cancer therapy. First class M.Pharm, MS Pharm, M. Tech in Pharmaceutical, Medicinal Chemistry with GATE, GPAT, CSIR UGC-NET qualification or equivalent examination.
Christian Medical College, Vellore, widely known as CMC, Vellore, is a private, Christian minority community-run medical college and hospital in Vellore, Tamil Nadu, India. This institute includes a network of primary, secondary and tertiary care hospitals.
Candidates should have experience in Biomedical Imaging, Biomedical signal processing, AI in health care etc. Expertise in developing and testing of Biomedical devices in class 2 and class 3 category will be an added advantage. Patent filed, granted in the area of biomedical devices will be preferred.
Master, Integrated Masters in Natural or Agricultural or Pharmaceutical Sciences, Animal Sciences OR Bachelors degree in Engineering or Technology or Medicine from a recognized University AND Two years experience in Research and Development in Industrial and Academic Institutions or Science and Technology Organizations and Scientific activities and services.
Elucidating the role of primary microcephaly-associated CPAP G-box domain in regulating centriole length and number. Post graduate degree in basic science or Graduate, Post graduate degree in professional course in any branch of Life Sciences, Biotechnology, Molecular Biology, Microbiology and Biochemistry.